AIDS: the risks to insurers, the threat to equity

Area of Science:

• Public Health
• Health Economics
• Medical Ethics

Background:

• The American healthcare system's reliance on private insurance creates challenges for managing the financial impact of the Acquired Immunodeficiency Syndrome (AIDS) epidemic.
• Insurance carriers are increasingly using antibody testing to mitigate financial risks associated with direct-pay health insurance pools.
• Employers have considered discriminatory practices, such as terminating employees with AIDS or excluding AIDS coverage from group policies.

Purpose of the Study:

• To examine the financial challenges posed by the AIDS crisis to the private health insurance industry.
• To explore potential solutions for risk distribution and ensuring healthcare access for individuals with AIDS.
• To discuss the ethical considerations surrounding healthcare costs and access in the context of the AIDS epidemic.

Main Methods:

• Analysis of the current healthcare financing landscape in the United States.
• Review of insurance industry practices, including antibody testing and policy exclusions.
• Exploration of proposed financial risk-sharing mechanisms and policy interventions.

Main Results:

• Private insurance models face significant financial strain due to the AIDS epidemic.
• Insurance companies are implementing risk-selection strategies, potentially limiting access for individuals with AIDS.
• Alternative models like Medicare expansion or state-sponsored pools are viable options for risk management.

Conclusions:

• The financial demands of the AIDS crisis necessitate a re-evaluation of private health insurance's role.
• Ethical considerations of cost and access may drive a renewed debate for national health insurance.
• Policy interventions are crucial to ensure equitable healthcare access and financial stability amidst the epidemic.